These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 8376525)

  • 1. Simplification of the mass spectrometric assay for the major urinary metabolite of prostaglandin D2.
    Awad JA; Morrow JD; Roberts LJ
    J Chromatogr; 1993 Jul; 617(1):124-8. PubMed ID: 8376525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of the major urinary metabolite of prostaglandin D2 in the circulation: demonstration of elevated levels in patients with disorders of systemic mast cell activation.
    Awad JA; Morrow JD; Roberts LJ
    J Allergy Clin Immunol; 1994 May; 93(5):817-24. PubMed ID: 8182221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of the major urinary metabolite of prostaglandin D2 by a stable isotope dilution mass spectrometric assay.
    Morrow JD; Prakash C; Awad JA; Duckworth TA; Zackert WE; Blair IA; Oates JA; Roberts LJ
    Anal Biochem; 1991 Feb; 193(1):142-8. PubMed ID: 2042739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved diagnosis of mastocytosis by measurement of the major urinary metabolite of prostaglandin D2.
    Morrow JD; Guzzo C; Lazarus G; Oates JA; Roberts LJ
    J Invest Dermatol; 1995 Jun; 104(6):937-40. PubMed ID: 7769262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A stable isotope dilution mass spectrometric assay for the major urinary metabolite of PGD2.
    Morrow JD; Prakash C; Duckworth TA; Zackert WE; Blair IA; Oates JA; Roberts LJ
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():315-8. PubMed ID: 1825560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isomeric prostaglandin F2 compounds arising from prostaglandin D2: a family of icosanoids produced in vivo in humans.
    Wendelborn DF; Seibert K; Roberts LJ
    Proc Natl Acad Sci U S A; 1988 Jan; 85(2):304-8. PubMed ID: 3422430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of the PGD2 urinary metabolite 9 alpha-hydroxy-11, 15-dioxo-2,3,18,19-tetranorprost-5-ene-1,20-dioic acid by stable isotope dilution mass spectrometric assay.
    Roberts LJ
    Methods Enzymol; 1982; 86():559-70. PubMed ID: 6752644
    [No Abstract]   [Full Text] [Related]  

  • 8. Increased formation of thromboxane in vivo in humans with mastocytosis.
    Morrow JD; Oates JA; Roberts LJ; Zackert WE; Mitchell TA; Lazarus G; Guzzo C
    J Invest Dermatol; 1999 Jul; 113(1):93-7. PubMed ID: 10417625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic fate of endogenously synthesized prostaglandin D2 in a human female with mastocytosis.
    Roberts LJ; Sweetman BJ
    Prostaglandins; 1985 Sep; 30(3):383-400. PubMed ID: 3864190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analytical and clinical validation of an LC-MS/MS method for urine leukotriene E4: A marker of systemic mastocytosis.
    Lueke AJ; Meeusen JW; Donato LJ; Gray AV; Butterfield JH; Saenger AK
    Clin Biochem; 2016 Sep; 49(13-14):979-82. PubMed ID: 26908217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandin D2 generation after activation of rat and human mast cells with anti-IgE.
    Lewis RA; Soter NA; Diamond PT; Austen KF; Oates JA; Roberts LJ
    J Immunol; 1982 Oct; 129(4):1627-31. PubMed ID: 6809826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mast cell disease and its diagnosis.
    Tharp MD
    J Invest Dermatol; 1995 Jun; 104(6):885-6. PubMed ID: 7769253
    [No Abstract]   [Full Text] [Related]  

  • 13. Transformation of prostaglandin D2 to 9 alpha, 11 beta-(15S)-trihydroxyprosta-(5Z,13E)-dien-1-oic acid (9 alpha, 11 beta-prostaglandin F2): a unique biologically active prostaglandin produced enzymatically in vivo in humans.
    Liston TE; Roberts LJ
    Proc Natl Acad Sci U S A; 1985 Sep; 82(18):6030-4. PubMed ID: 3862115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 9-Deoxy-delta 9, delta 12-13,14-dihydroprostaglandin D2, a metabolite of prostaglandin D2 formed in human plasma.
    Kikawa Y; Narumiya S; Fukushima M; Wakatsuka H; Hayaishi O
    Proc Natl Acad Sci U S A; 1984 Mar; 81(5):1317-21. PubMed ID: 6584883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical diagnosis of systemic mast cell disorders.
    Roberts LJ; Oates JA
    J Invest Dermatol; 1991 Mar; 96(3):19S-24S; discussion 24S-25S. PubMed ID: 2002247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the role of PGD2 metabolites as markers of mast cell activation in asthma.
    O'Sullivan S
    Acta Physiol Scand Suppl; 1999 Apr; 644():1-74. PubMed ID: 10352758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of the major urinary metabolite of 15-F2t-isoprostane (8-iso-PGF2alpha) by a stable isotope dilution mass spectrometric assay.
    Morrow JD; Zackert WE; Yang JP; Kurhts EH; Callewaert D; Dworski R; Kanai K; Taber D; Moore K; Oates JA; Roberts LJ
    Anal Biochem; 1999 May; 269(2):326-31. PubMed ID: 10222005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anaphylactic release of thromboxane A2, prostaglandin D2, and prostacyclin from human lung parenchyma.
    Schulman ES; Newball HH; Demers LM; Fitzpatrick FA; Adkinson NF
    Am Rev Respir Dis; 1981 Oct; 124(4):402-6. PubMed ID: 6170242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anaphylactic- and calcium-dependent generation of prostaglandin D2 (PGD2), thromboxane B2, and other cyclooxygenase products of arachidonic acid by dispersed human lung cells and relationship to histamine release.
    Holgate ST; Burns GB; Robinson C; Church MK
    J Immunol; 1984 Oct; 133(4):2138-44. PubMed ID: 6206153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The flush syndrome: an expression of systemic mastocytosis with increased prostaglandin D2 production.
    Kootte AM; Haak A; Roberts LJ
    Neth J Med; 1983; 26(1):18-20. PubMed ID: 6572798
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.